Dr. Dicker on DNA Sequencing for Prostate Cancer

Adam P. Dicker, MD, PhD
Published: Wednesday, May 10, 2017



Adam P. Dicker, MD, PhD, professor, chair, Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, discusses DNA sequencing for patients with prostate cancer.

According to Dicker, DNA sequencing has become less expensive, making it more accessible for patients. The ability to sequence a patient’s DNA can not only help inform the physician on how a patient will respond to therapy but also how the patient will react to toxicities.

Over the next 5 years with the increase in technology, more information regarding DNA sequencing will become available.
 


Adam P. Dicker, MD, PhD, professor, chair, Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, discusses DNA sequencing for patients with prostate cancer.

According to Dicker, DNA sequencing has become less expensive, making it more accessible for patients. The ability to sequence a patient’s DNA can not only help inform the physician on how a patient will respond to therapy but also how the patient will react to toxicities.

Over the next 5 years with the increase in technology, more information regarding DNA sequencing will become available.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x